Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA
- 10 August 2005
- journal article
- Published by Elsevier in Neuroscience Research
- Vol. 53 (3) , 241-249
- https://doi.org/10.1016/j.neures.2005.06.021
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesisHuman Molecular Genetics, 2003
- Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type HuntingtinJournal of Biological Chemistry, 2003
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Specific inhibition of Huntington's disease gene expression by siRNAs in cultured cells.Proceedings of the Japan Academy, Series B, 2003
- Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamineBiochemical and Biophysical Research Communications, 2002
- Expanding small RNA interferenceNature Biotechnology, 2002
- Inhibition of Huntingtin Synthesis by Antisense OligodeoxynucleotidesMolecular and Cellular Neuroscience, 2000
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996